dna peptide conjugates Oligonucleotide analogues conjugated to carrier peptides - Peptide-oligonucleotide conjugate DNA−peptide conjugates Unlocking the Potential of DNA Peptide Conjugates: A Comprehensive Exploration

Peptide DNAcoupled nanoparticles ppt DNA peptide conjugates represent a sophisticated class of molecular constructs that merge the unique properties of both nucleic acids and peptidesInflammation-triggered self-immolative conjugates enable .... These conjugates are formed by covalently linking a DNA or oligonucleotide sequence to a synthetic peptide. This fusion creates novel molecular entities with enhanced functionalities, opening doors to a wide array of applications in fields ranging from therapeutics to nanotechnology. The inherent programmability of DNA combined with the diverse biological activities of peptides allows for the design of highly tailored molecules with specific binding capabilities, targeted delivery mechanisms, and self-assembly properties.

The fundamental structure of DNA peptide conjugates involves a single-stranded DNA linked to a synthetic peptide. This linkage can be achieved through various sophisticated conjugation chemistries, each offering specific advantages. One common approach involves DNA-peptide conjugation where a new amide bond is formed between an amino function on the peptide and an activated group on the oligonucleotide. Techniques like native chemical ligation and click chemistry are also widely employed for their efficiency and specificity in creating these peptide-oligonucleotide conjugates. The ability to precisely control the attachment point and the nature of the linker is crucial for optimizing the performance of the final conjugate作者：BAR Williams·2010·被引用次数：56—Peptide-oligonucleotideconjugates(POCs) are molecular chimeras composed of a nucleic acid moiety covalently attached to a polypeptide moiety..

The versatility of DNA peptide conjugates is underscored by their diverse applications. In therapeutic contexts, these conjugates are being explored for their potential in drug delivery and gene therapy. For instance, DNA-NLS conjugates have shown promise as a viable strategy for non-viral gene therapy, enabling enhanced nuclear delivery of genetic materialPeptide-oligo conjugatescan also be used as DNA-directed immobilizationto a solid support for binding to antigens.. The peptide component can act as a targeting moiety, guiding the conjugate to specific cells or tissues, while the DNA portion can deliver therapeutic payloads. Furthermore, the conjugation of peptides to oligonucleotides can protect them from degradation, a common challenge for oligonucleotide-based therapeutics.Peptide-drugconjugates(PDCs) are a sub-class of drugconjugatesthat show great promise in targeted cancer therapies. They are composed of a shortpeptide, ... As highlighted in some research, Antisense conjugate DNAs have demonstrated significantly higher inhibitory effects on specific enzymatic activities compared to their native counterpartsPeptide–oligonucleotide conjugates as nanoscale building ....

Beyond therapeutics, DNA peptide conjugates are emerging as powerful tools in materials science and nanotechnology. Their ability to undergo self-assembly of higher-ordered protein-like structures is particularly noteworthy. This phenomenon arises from the interplay between the predictable structural organization of DNA and the conformational flexibility of peptides.作者：Y Altrichter·2020·被引用次数：14—Conjugation of peptides with oligonucleotidesoffers opportunities for combining the strengths of both biopolymer classes. These self-assembling systems can be designed to form intricate architectures with potential applications in biosensing, scaffolding for tissue engineering, and the creation of novel nanomaterialsPeptide-DNA conjugates as building blocks for de novo .... The peptide component can mimic natural proteins and interact with specific molecular targets, including enzymes and receptors, further expanding the functional possibilities of these conjugates.

The synthesis of custom DNA-peptide conjugates is a specialized area, with companies offering tailored services to meet specific research and development needs. These services often employ selective cross-linking chemistries and can be performed at various synthesis scales. The development of efficient and reliable synthetic methods is paramount for the widespread adoption of DNA peptide conjugatesand peptide-driven self-assembly in DNA–peptide conjugates. For example, DNA-peptide conjugates can be synthesized by condensing partially protected peptide fragments and oligonucleotides on a solid support.

The field of peptide-oligonucleotide conjugation is rapidly advancing, with ongoing research focused on developing new chemistries and exploring novel applications. The combination of DNA's programmability and peptide's biological relevance offers a powerful platform for innovation. Whether for targeted drug delivery, gene modulation, or the construction of complex nanoscale architectures, DNA peptide conjugates are poised to play an increasingly significant role in scientific and technological advancementsPeptide-oligo conjugatescan also be used as DNA-directed immobilizationto a solid support for binding to antigens.. The ability to precisely engineer these molecules allows researchers to harness the synergistic benefits of both DNA and peptide components, leading to the creation of advanced functional materials and therapeutic agentsTuning dynamic DNA- and peptide-driven self. The growing interest in peptide-oligonucleotide conjugation chemistry and therapeutic applications reflects the immense potential of this interdisciplinary field.